Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Clinical trial NCT02068586 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02068586
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Iris Melanoma Stage I Intraocular Melanoma Stage IIA Intraocular Melanoma Stage IIB Intraocular Melanoma Stage IIIA Intraocular Melanoma Stage IIIB Intraocular Melanoma Stage IIIC Intraocular Melanoma Stage I Uveal Melanoma AJCC V7 Stage II Uveal Melanoma AJCC V7 Stage III Uveal Melanoma AJCC V7

Start date: 2014-11-19
Primary completion: 2026-12-31
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.